Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

0.8675
-0.0060-0.69%
Post-market: 0.92800.0605+6.97%19:57 EDT
Volume:76.62K
Turnover:66.81K
Market Cap:4.26M
PE:0.00
High:0.9279
Open:0.8700
Low:0.8247
Close:0.8735
52wk High:77.63
52wk Low:0.7250
Shares:4.91M
Float Shares:4.88M
Volume Ratio:0.20
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-262.2873
EPS(LYR):-803.9466
ROE:-548.83%
ROA:-38.04%
PB:0.64
PE(LYR):0.00

Loading ...

Jaguar Health Inc: Q2 Total REV $1.2 Mln, EPS $-15.6

THOMSON REUTERS
·
Aug 20

Jaguar Health Q2 EPS $(15.70) Up From $(358.94) YoY, Sales $1.225M Down From $2.979M YoY

Benzinga Earnings
·
Aug 20

Jaguar Health FY26 Q2 Net Loss Narrows 80.7% to USD 4.08 Million; Revenue Rises 314% to USD 21.5 Million

Reuters
·
Aug 20

Jaguar Health Schedules Investor Webcast on Q2 2026 Financials

Reuters
·
Aug 18

Jaguar Health Delays Q2 Form 10-Q Filing After Holdup Compiling Subsequent-Event Information

Reuters
·
Aug 15

Jaguar Health Meets Conditions to Receive $2 Million Holdback Payment from Future Pak License Deal

Reuters
·
Aug 05

Jaguar Health Announces Special Shareholder Meeting

Reuters
·
Aug 04

Jaguar Health announces findings from surveys of dog owners, vet oncologists

TIPRANKS
·
Jul 28

Jaguar Health Plans Neonorm Dog Launch Via Amazon, Chewy

Reuters
·
Jul 28

Jaguar Health Announces Special Shareholder Meeting

Reuters
·
Jul 25

Jaguar Health announces additional infant to receive crofelemer powder

TIPRANKS
·
Jul 22

Jaguar Health Announces Press Release on Crofelemer Compassionate Use for Infant MVID Patient in EU

Reuters
·
Jul 22

Jaguar Health - Registers Resale of up to 40.8 Mln Shares of Common Stock by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Jul 16

Jaguar Animal Health Signs New Crofelemer Supply Agreement

TIPRANKS
·
Jul 15

Jaguar Health Signs New Crofelemer Manufacturing, Supply Deal with Alivus Through March 2029

Reuters
·
Jul 15

Jaguar Health - Napo and Alivus Enter New Manufacturing and Supply Agreement for Crofelemer on July 9, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 15

Jaguar Health - 2026 Agreement Set to Expire on March 31, 2029 - SEC Filing

THOMSON REUTERS
·
Jul 15

Jaguar Health Completes Series O Preferred Conversion into Common Shares at 3.209-to-1 Ratio

Reuters
·
Jul 02

Jaguar Health provides recap of presentations of crofelemer at ESPGHAN

TIPRANKS
·
Jun 30

Jaguar Health Says Pediatric Intestinal Failure Trial Data Show Crofelemer Cuts Parenteral Support Needs up to 48%

Reuters
·
Jun 30